Skip to main content

Manulife Mulfact CDN Smid Cap Idx ETF(MCSM-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Manulife Mulfact CDN Smid Cap Idx ETF up on Friday (MCSM)

Automated Summaries - The Globe and Mail - Thu Apr 11, 4:02PM CDT

Manulife Mulfact CDN Smid Cap Idx ETF opened trading today at $39.53 and closed at $39.51. prices ranged from $39.49 to $39.53.

The price advanced 0.56% from the previous day's close of $39.29.

During the day across North America, the TSX Composite closed -0.73% at 22199.13, the S&P 500 closed -0.95% at 5160.64, the Dow Jones Industrial Average closed -1.09% at 38461.51 and the Nasdaq Composite closed -0.84% at 16170.36.

Manulife Mulfact CDN Smid Cap Idx ETF has listed on the Toronto Stock Exchange (TSX) under the ticker MCSM.

Trading volume was 1,976 on 1 total trades. On average, Manulife Mulfact CDN Smid Cap Idx ETF has traded 974 shares over 5 days and 1,742 year-to-date.

The TSX market on the whole today saw 2,898 price advancers against 2,320 declines and 129 unchanged.

During the prior 52 weeks, MCSM.TO has traded as high as $39.53 (April 05,2024) and low as $33.93 (October 27,2023). Moreover, the shares have advanced 8.42% in the last 52 weeks, while they have advanced 9.20% since the start of 2024.

Following today's trading, Manulife Mulfact CDN Smid Cap Idx ETF has a market capitalization of $266.69 million on a float of 6,750 shares outstanding. Its annual EPS is $None.

Manulife Mulfact CDN Smid Cap Idx ETF is a None company headquartered in, None.

The Manulife Multifactor Canadian SMID Cap Index ETF seeks to track the performance of the John Hancock Dimensional Canadian SMID Cap Equity Index (CAD), before fees and expenses..

Currently, Manulife Mulfact CDN Smid Cap Idx ETF has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe